It's one of the best-known "mitochondria" supplements on the shelf, and it's often marketed as fuel for tired, aging muscles. A new systematic review and meta-analysis of randomized trials suggests the muscle case for coenzyme Q10 (CoQ10) is much weaker than the marketing implies.
The paper, published in Antioxidants (PubMed 42939793; DOI 10.3390/antiox15101219; PMC13700822), found no clearly meaningful benefit for aerobic capacity, muscle health, or physical function.
What the researchers actually did
The rationale is simple. Age-related declines in physical capacity may partly reflect impaired mitochondrial energy production and oxidative stress. CoQ10 plays a role in both, so supplementing it seems like a reasonable idea.
To test it, the team searched MEDLINE, Embase, Web of Science, Scopus, and CENTRAL for randomized controlled trials of oral CoQ10 lasting at least two weeks. They included adult populations with a study-level mean or median age of 40 or older.
- 33 trials with 3,317 randomized participants were included.
- 21 trials contributed data to the meta-analysis.
- Directly usable evidence drove the primary models. Estimates that depended on assumptions were used only in sensitivity analyses.
The headline number: VO2max
The most-watched stamina measure is relative VO2peak/VO2max, which reflects how efficiently the body uses oxygen during hard exercise.
- Pooled difference: +0.73 mL/kg/min
- 95% confidence interval: -0.07 to 1.54
- Studies/participants: 5 studies, n = 172
- Heterogeneity: I² = 0%
- Certainty of evidence: low
The interval crosses zero, so the result is compatible with no benefit at all. The authors describe the estimate as small and imprecise. A bump of under one mL/kg/min is not a dramatic change even if it were real.
The rest of the muscle scorecard
VO2max wasn't the only outcome that came up short. The authors report that primary estimates were also uncertain for:
- 6-minute walking distance
- Handgrip strength
- Lower-limb strength
- Chair-rise performance
- Exercise duration
- Muscle and lean-tissue quantity
Sensitivity analyses did not materially change the interpretation. Evidence certainty was low or very low for every key outcome. The authors conclude that current evidence "does not establish clinically meaningful benefits" of CoQ10 for aerobic capacity, muscle health, or physical function.
How to read this (and what it doesn't say)
"Not established" is not the same as "proven useless." Low and very low certainty mean the data are thin, imprecise, or limited by study quality. Only five studies with 172 people fed the VO2max estimate. A small real effect could be hiding in that noise, but the current evidence doesn't show one.
This is not a statin or heart failure verdict. The abstract doesn't analyze statin users or people with heart failure as specific groups. It covers adult populations with a mean or median age of 40 or older, looking at muscle and physical-capacity outcomes. Don't read it as a ruling on CoQ10 for statin-related muscle symptoms or for heart conditions. That would need separate evidence.
These are human randomized trials, not animal or observational work. That makes the design stronger than much supplement research. But the pooled evidence is still graded low or very low, so the conclusion is "no clear benefit shown," not "definitely no effect."
Practical takeaways
Dose and timing. The abstract doesn't report dosing or timing, so this review can't tell you an effective dose for muscle or stamina. Anyone wanting the details should check the full text on PMC. The bigger point is that no dose or schedule has been shown here to deliver a meaningful muscle benefit.
Who might reconsider buying it. If your main goal is stronger legs, a better walking test, a higher VO2max, or more lean mass after 40, this paper gives you little reason to expect CoQ10 to deliver. The money may be better spent elsewhere.
Who should talk to a clinician first. If you take CoQ10 for a medical reason, or take it alongside prescription drugs, don't stop or start anything based on this meta-analysis alone. It addressed muscle and physical-capacity outcomes, not those medical uses.
What has better support. This paper didn't test exercise. But regular resistance and aerobic training are the well-established ways to protect strength and fitness with age, and they're the obvious comparison point for any supplement claim.
Bottom line
The "mitochondria in a capsule" pitch sounds compelling, but across 33 randomized trials in adults 40 and older, CoQ10 did not show a clearly meaningful improvement in VO2max, walking distance, grip, leg strength, chair rise, or lean mass. The evidence is low-certainty, so the door isn't fully closed, but the burden of proof now sits with the supplement.
Source: Liu X, et al. Effects of Coenzyme Q10 Supplementation on Muscle Health and Physical Capacity in Middle-Aged and Older Adults. Antioxidants (Basel). 2026;15(10):1219. PubMed | DOI. The authors declared no conflicts of interest. This article is informational and not medical advice.